摘要
目的:探讨沉默DNMT1和DNMT3b基因对胰腺癌BxPC-3细胞p16,RASSF1A基因启动子甲基化的影响。方法:将胰腺癌BxPC-3细胞分为5组:DNMT1干扰组(转染DNMT1-siRNA),DNMT3b干扰组(转染DNMT3b-siRNA),双重干扰组(转染DNMT1+DNMT3b-siRNA),阴性对照组(转染阴性siRNA)和空白对照组(转染脂质体)。转染48 h后,应用荧光定量PCR法和Western blot法分别检测细胞中DNMT1和DNMT3b的mRNA及蛋白的表达水平;甲基化特异性PCR法检测p16和RASSF1A基因启动子甲基化。结果:与空白对照组和阴性对照组比较,各干扰组目的基因的mRNA及蛋白表达量均明显降低(均P<0.01)。空白对照组与阴性对照组p16和RASSF1A基因甲基化阳性;DNMT1干扰组和双重干扰组p16基因甲基化阴性,RASSF1A基因部分甲基化;DNMT3b干扰组p16基因部分甲基化,RASSF1A基因甲基化阳性。结论:DNMT1单干扰对胰腺癌BxPC-3细胞p16和RASSF1A基因的去甲基化作用优于DNMT3b单干扰,DNMT1和DNMT3b双重干扰无明显的协同效应;提示DNMT1是胰腺癌去甲基化治疗的一个有效靶点。
Objective: To investigate the effect of gene silencing of DNMT1 and DNMT3b on methylation in the promoter region of p16 and RASSF1A gene in pancreatic carcinoma BxPC-3 cells. Methods: The pancreatic carcinoma BxPC-3 cells were divided into five groups,which included the DNMT1 interference group(transfected with DNMT1-siRNA),DNMT3b interference group(transfected with DNMT3b-siRNA),double interference group(transfected with DNMT1+DNMT3b-siRNA),negative control group(transfected negative-siRNA) and blank control group(transfected with lipofectamine).Forty-eight hours after transfection,the mRNA and protein expression of DNMT1 and DNMT3b were analyzed by real-time RT-PCR and Western blot,and the methylation status in the promoter region of p16 and RASSF1A gene was detected with methylation-specific PCR(MSP). Results: Compared with the negative or blank control group,the mRNA and protein expression levels of the targeted genes were all markedly down-regulated in each interference group(all P0.01).The methylation status of p16 and RASSF1A gene was positive in both the blank and negative control group;the p16 gene was unmethylated and RASSF1A gene was partially methylated in DNMT1 interference group and double interference group;the p16 gene was partially methylated and RASSF1A gene showed methylation-positive state in DNMT3b interference group. Conclusion: DNMT1 interference has better effect than DNMT3b interference on demethylation in BxPC-3 cells,and the double knockdown of DNMT1 and DNMT3b exerts no synergistic action.DNMT1 could serve as an effective target for the demethylation therapy of pancreatic carcinoma.
出处
《中国普通外科杂志》
CAS
CSCD
北大核心
2012年第3期322-326,共5页
China Journal of General Surgery
基金
江西省教育厅科学技术研究项目(GJJ08077)